More tools:Markets·Screener·Research·Chat

Legend Biotech Corporation American Depositary Shares (LEGN) Financial Statements

Legend Biotech Corporation American Depositary Shares
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00TTGH6N2
XNAS · usd
19.91▼ 0.58 (-2.83%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close20.49
Day's Range19.76 – 20.52
52-Week Range16.24 – 37.50
Volume1.4M
Avg Volume2.0M
Share Statistics
Shares Outstanding
Employees2,900
ExchangeXNAS
Listed2020-06-05
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Legend Biotech Corporation American Depositary Shares (LEGN)
What is Legend Biotech Corporation American Depositary Shares's Market Cap?
Legend Biotech Corporation American Depositary Shares's Market Cap is $7.4B, based on as-reported figures from SEC (XBRL) filings.
What is Legend Biotech Corporation American Depositary Shares's Enterprise Value?
Legend Biotech Corporation American Depositary Shares's Enterprise Value is $6.5B, based on as-reported figures from SEC (XBRL) filings.
What is Legend Biotech Corporation American Depositary Shares's Price / Sales?
Legend Biotech Corporation American Depositary Shares's Price / Sales is 7.2×, based on as-reported figures from SEC (XBRL) filings.
What is Legend Biotech Corporation American Depositary Shares's EV / Revenue?
Legend Biotech Corporation American Depositary Shares's EV / Revenue is 6.3×, based on as-reported figures from SEC (XBRL) filings.
What is Legend Biotech Corporation American Depositary Shares's Revenue (TTM)?
Legend Biotech Corporation American Depositary Shares's Revenue (TTM) is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Legend Biotech Corporation American Depositary Shares's Net Income (TTM)?
Legend Biotech Corporation American Depositary Shares's Net Income (TTM) is -$296.8M, based on as-reported figures from SEC (XBRL) filings.
What is Legend Biotech Corporation American Depositary Shares's Diluted EPS (TTM)?
Legend Biotech Corporation American Depositary Shares's Diluted EPS (TTM) is -0.80, based on as-reported figures from SEC (XBRL) filings.
What is Legend Biotech Corporation American Depositary Shares's Net Debt?
Legend Biotech Corporation American Depositary Shares's Net Debt is -$901.9M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
REVENUE
License and other revenue
Collaboration revenue
Total revenue
Cost of collaboration revenue
Cost of license and other revenue
Research and development expenses
Administrative expenses
Selling and distribution expenses
Other operating expense
Operating loss
Finance costs
Finance income
Other (expense)/ income, net
Loss before tax
Income tax (expense)/benefit
Net loss